R -- High Purity Custom Design Peptide Synthesis

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting sources capable of providing high purity custom-designed peptide synthesis under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The contract will include a base year with options to extend for up to four additional years. Contractors are required to synthesize peptides in 25 mg quantities with a purity level exceeding 80%, verified through HPLC purification and mass spectrometry confirmation. Each delivery order will specify peptides with varying amino acid sequences and lengths, and all products must be delivered within 45 days of the request. This procurement primarily emphasizes the ability to produce diverse custom peptides meeting strict quality standards and prompt turnaround times. The solicitation is identified as NIAID-VRC-04-52 and was posted on January 15, 2004. Questions about this requirement are directed to Ivan Hernandez, while additional contact information is provided for Terrie L. Nestor. The contract aims to support research needs requiring reliable access to high-quality peptides tailored to specific experimental designs.